Current Stem Cell Research & Therapy
Title:Meet Our Editorial Board Member
Volume: 12 Issue: 2
Author(s): Takehiko Mori
Affiliation:
Export Options
About this article
Cite this article as:
Mori Takehiko, Meet Our Editorial Board Member, Current Stem Cell Research & Therapy 2017; 12 (2) . https://dx.doi.org/10.2174/1574888X1202161216183934
DOI https://dx.doi.org/10.2174/1574888X1202161216183934 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
“Antisurvival” Factor Treatment for Hormone Refractory Prostate Cancer: Secondary Hormonal Ablation Using Somatostatin Analogs
Current Cancer Therapy Reviews Comparative Proteomics and Bioinformatics Analysis of Tissue from Non-Small Cell Lung Cancer Patients
Current Proteomics Analysis of Metabolic Parameters Coming from Basal and Interim PET in Hodgkin Lymphoma
Current Medical Imaging Dendritic Cells and their Receptors in Antitumor Immune Response
Current Molecular Medicine Repositioning the Old Fungicide Ciclopirox for New Medical Uses
Current Pharmaceutical Design MicroRNAs in Myeloid Hematological Malignancies
Current Genomics Telomerase Therapeutics for Degenerative Diseases
Current Molecular Medicine Discovery of Hedgehog Antagonists for Cancer Therapy
Current Medicinal Chemistry Cyclin-Dependent Kinase Inhibition by Flavoalkaloids
Mini-Reviews in Medicinal Chemistry Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases
Current Cancer Drug Targets Unexpected High Levels of Vorinostat when Combined with Vinorelbine in Patients with Advanced Cancer
Current Clinical Pharmacology Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
Current Cancer Drug Targets Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews Recent Developments in Cardiovascular Drug Therapy: Treatment of Atrial Arrhythmias with New Class III Drugs and beyond
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Current Developments in Anti-Fungal Agents
Current Medicinal Chemistry - Anti-Infective Agents A Prooxidant Mechanism for the Anticancer and Chemopreventive Properties of Plant Polyphenols
Current Drug Targets Radiosensitizing Potential of Epigenetic Anticancer Drugs
Anti-Cancer Agents in Medicinal Chemistry PET Radiopharmaceuticals for Personalized Medicine
Current Drug Targets Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer
Recent Patents on Anti-Cancer Drug Discovery Targeting CREB for Cancer Therapy: Friend or Foe
Current Cancer Drug Targets